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Wednesday, March 2 
10:30 - 12:00 Studio 2016  
jointly organised by Siemens Healthcare and Bayer HealthCare  
SY 1a  
Breast MRI: today and tomorrow  
Moderator:  
G.M. Newstead; Chicago, IL/US  
Breast MRI: practical tips on performing, reading and reporting  
L. Umutlu; Essen/DE  
Since the first introduction of breast MRI, dynamic contrast-enhanced magnetic 
resonance imaging of the breast has gone through substantial developments of 
image acquisition and evaluation, evolving to become a mandatory component 
of breast diagnostics. Aside from high-quality MR systems and dedicated 
breast coils, breast MRI requires high standards of comprehension of 
acquisition and evaluation skills. While various organizations provide 
guidelines to perform breast MRI, this highly demanding imaging technique still 
lacks clean universally accepted standardization of imaging. Apart from 
standardized imaging, standardized reading and reporting is another highly 
important issue to enhance the clinical acceptance of breast MR imaging. The 
current BI-RADS® Atlas provided by the American College of Radiology 
constitutes an excellent guide for standardized reading and reporting of breast 
MRI, promoting high acceptance among clinicians, surgeons, radiologists and 
patients. The aim of this presentation is to give practical tips on universally 
accepted, high-quality breast MRI imaging as well as standardized reading in 
accordance with the current BI-RADS® Lexicon. 
Learning Objectives: 
1. To learn how to perform high-quality breast MRI in accordance with current 
guidelines. 
2. To learn how to read and report breast MR imaging in accordance with the 
current BI-RADS® lexicon. 
Abbreviated breast MRI: first post-contrast subtracted images and 
maximum-intensity projection - a novel approach to breast cancer 
screening with MRI  
C.K. Kuhl; Aachen/DE  
Purpose: We investigated whether an abbreviated protocol (AP), consisting of 
only one pre- and one postcontrast acquisition and their derived images (first 
postcontrast subtracted [FAST] and maximum-intensity projection [MIP] 
images), was suitable for breast magnetic resonance imaging (MRI) screening. 
Methods: We conducted a prospective observational reader study in 443 
women at mildly to moderately increased risk who underwent 606 screening 
MRIs. Eligible women had normal or benign digital mammograms and, for 
those with heterogeneously dense or extremely dense breasts (n = 427), 
normal or benign ultrasounds. Expert radiologists reviewed the MIP image first 
to search for significant enhancement and then reviewed the complete AP 
(consisting of MIP and FAST images and optionally their non-subtracted 
source images) to characterize enhancement and establish a diagnosis. Only 
thereafter was the regular full diagnostic protocol (FDP) analysed. Results: MRI 
acquisition time for FDP was 17 minutes, versus 3 minutes for the AP. Average 
time to read the single MIP and complete AP was 2.8 and 28 seconds, 
respectively. Eleven breast cancers (four ductal carcinomas in situ and seven 
invasive cancers; all T1N0 intermediate or high grade) were diagnosed, for an 
additional cancer yield of 18.2 per 1,000. MIP readings were positive in 10 
(90.9%) of 11 cancers and allowed establishment of the absence of breast 
cancer, with a negative predictive value (NPV) of 99.8% (418 of 419). 
Interpretation of the complete AP, as with the FDP, allowed diagnosis of all 
cancers (11 [100%] of 11). Specificity and positive predictive value (PPV) of AP 
versus FDP were equivalent (94.3% v 93.9% and 24.4% v 23.4%, 
respectively). Conclusion: An MRI acquisition time of 3 minutes and an expert 
radiologist MIP image reading time of 3 seconds are sufficient to establish the 
absence of breast cancer, with an NPV of 99.8%. With a reading time <30 
seconds for the complete AP, diagnostic accuracy was equivalent to that of the 
FDP and resulted in an additional cancer yield of 18.2 per 1,000. © 2014 by 
American Society of Clinical Oncology. 
Perspectives in diffusion weighted breast imaging  
S. Bickelhaupt; Heidelberg/DE  
Diffusion-weighted MR imaging (DWI) has become a useful part of diagnostic 
MR protocols in many fields of oncology. DWI of the breast has been applied 
within conventional dynamic contrast-enhanced MRI (DCE-MRI) aiming to 
improve the accuracy of the examination, in particular with regard to reduce 
false-positive findings and thus increase specificity. DWI is based on 
visualizing the free Brownian motion of water molecules in tissue and thought 
to be closely related to cellularity. Depending on the sequence protocol with 
use of a specific set of b-values different tissue parameters can be calculated 
including perfusion, apparent diffusion coefficient (ADC) and kurtosis giving 
insights into different biologic features beyond morphology. By providing 
additive biophysiological information on suspicious lesions DWI might be of 
added value not only in DCE-MRI but also as an adjunct used in the 
clarification of suspicious lesions detected by conventional x-ray 
mammograms. Initial experiences are promising suggesting the diagnostic 
potential of DWI to separate benign from malignant lesions which were initially 
detected on x-ray mammography during screening. Since the technique does 
not require for intravenous contrast agent administration or long examination 
times, it might even be of special interest to be used as a non-invasive adjunct 
in breast cancer screening programs to reduce the relatively high number of 
false-positive lesions triggering biopsies. However, further studies and 
harmonization in terms of imaging parameters and quality assurance are 
needed prior to discuss a broader use in breast imaging. 
Learning Objectives: 
1. To understand how DWI might increase accuracy of conventional DCE-MRI 
of the breast. 
2. To appreciate that, when used as an adjunct in x-ray mammography, breast 
cancer screening DWI has the potential to reduce the number of false positive 
findings. 
3. To learn that implementation of DWI in clinical routine requires 
standardisation of DWI sequence parameters as well as sustained quality 
assurance. 
Optimising breast MRI using novel imaging strategies, dedicated reading 
protocols and computer aided diagnosis  
R.M. Mann; Nijmegen/NL  
Although breast MRI has the highest sensitivity for cancer of all currently 
widely used methods of breast evaluation, it is not infallible. Limitations are for 
example long acquisition time and long reading times. In addition, in screening, 
cancers that are clearly visible in scans might still be missed due to overlook or 
interpretation errors. This implies that there is still ample room for 
improvement. Part of this can be achieved by novel acquisition approaches 
that are more tailored to the clinical question. This would enable a higher 
patient throughput while simultaneously reducing the workload for reporting 
radiologists, and decreasing the costs associated with the technique. 
Dedicated post-processing and simple hanging protocols will allow subsequent 
fast evaluation of the MRI scans. Nonetheless, this will likely not prevent all 
reading errors and hence either second reading, or computer-assisted lesion 
detection might be required to further optimize sensitivity of breast MRI. Also, 
to prevent an unnecessary high number of recalls, the specificity of breast MRI 
must be preserved. Also in this area automated image analysis can play a 
major role; possibly even changing the scan protocol based upon direct 
evaluation of image findings. 
Learning Objectives: 
1. To appreciate that breast MRI has a high sensitivity, but is not infallible. 
2. To understand that novel acquisition protocols tailored to the clinical 
question might be used to increase patient throughput and decrease costs. 
3. To learn that hanging protocols and CAD can be used to increase reading 
spead and optimise sensitivity and specificity. 
12:15 - 13:45 Studio 2016  
jointly organised by Siemens Healthcare and Bayer HealthCare  
SY 1b  
Multimodality lunch symposium: breast 
screening controversies  
Moderator:  
S.H. Heywang-Köbrunner; Munich/DE  
Breast screening controversies: viewpoint of the IARC  
S.H. Heywang-Köbrunner; Munich/DE  
In November 2014, after extensive preparations and literature search, a 
working group of 29 experts from 16 countries met to assess the existing data 
base on breast cancer screening. For screening of mammography remains the 
most important method for mass screening with the highest level of evidence. 
Due to technical improvements of the method and the screening chain and 
improvement of therapy the relevance of 20-30-year-old RCTs was questioned. 
Most robust data stem from high-quality observational studies (mostly 
incidence-based cohort studies combined with appropriately corrected case-
control studies. Mortality reduction per invited woman (irrespective of 
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 participation) ranges around 23% and for truly participating women around 
40%. Evidence for ages 50-74 was considered sufficient, for ages 40-49 
limited. Advantages outweigh side effects like false positives or overdiagnosis 
(calculated to range around 6%). The data base on ultrasound screening 
remains inadequate for assessing mortality reduction. Proof of increased 
detection (for the additional use of ultrasound) was considered limited, but 
associated with high false-positive rates. For tomosynthesis proof of increased 
detection was considered sufficient, while data on mortality reduction are still 
lacking. Data for mortality reduction by MRI were considered inadequate, while 
data of improved detection for mutation carriers were considered sufficient. An 
extended overview of the results will be published in the IARC Handbook, 
scheduled for release end of 2015. 
Evaluation of virtual touch tissue imaging quantification (VTIQ - 2D-SWE) 
in the assessment of BI-RADS® 3 and 4 lesions: can patient selection for 
biopsy be improved?  
M. Golatta; Heidelberg/DE  
Objective: To evaluate breast tissue stiffness with Virtual Touch Tissue 
Imaging Quantification (VTIQ) and to prospectively evaluate VTIQ as a new 
elastography method. Main focus is to improve the assessment of BI-RADS® 3 
and 4a lesions by restaging patients in according to a predefined VTIQ cutoff 
value of 3.5 m/s (37 kPa). The aim is to reduce unnecessary benign biopsies 
(improvement of specificity) without a loss of sensitivity. Materials and 
methods: The standard BI-RADS® ultrasound (US) category (BI-RADS® 3-4c) 
and VTIQ values are correlated with the histological result. It is assessed 
whether the probabilities for malignancies predicted with US according to BI-
RADS® differ from the probabilities for malignancies predicted by means of 
VTIQ only or by a combination of BI-RADS® and VTIQ measurements. 
Results: Preliminary findings and cases will be presented. Conclusion: VTIQ 
has been a hot topic in the last years. Few studies have evaluated Virtual 
Touch Tissue Imaging Quantification (VTIQ) as a new Shear Wave 
Elastography method in breast tissue, suggesting cutoff values for the 
differentiation of benign and malignant lesions, showing a high reliability and 
reproducibility and assessing the amount of precompression needed for 
optimal scanning. Improved specificity, achieved by combining standard 
ultrasound BI-RADS® classification with elastography, will help to eliminate 
unnecessary breast biopsies in the future. 
Learning Objectives: 
1. To give an update about the latest developments in the field of elastography 
(VTIQ). 
2. To learn why it is helpful to do less at some points: can elastography (VTIQ) 
help to improve patient selection for biopsy? 
Is digital breast tomosynthesis ready for mammo-screening?  
S. Zackrisson; Malmö/SE  
Digital breast tomosynthesis, DBT, is a 3D mammography where low-dose 
images are acquired of the breast and then reconstructed into thin slices. It 
reduces the effect of overlapping tissue and hence facilitates breast cancer 
detection. It is well known that mammography sensitivity is hampered by dense 
breast tissue obscuring tumours and up to 30% of the tumours are not 
detected at screening. The question is whether tomosynthesis may replace 
mammography in screening? To answer that question, large population-based 
trials are needed. At present, data are published from three prospective, 
population-based trials investigating 2-view mammography + 2-view 
tomosynthesis (OTST and STORM) and the MBTST investigating one-view 
tomosynthesis versus two-view mammography. The studies have all shown a 
significant increase in breast cancer detection of 30-40%, while the results on 
recall rates are slightly inconsistent. Furthermore, several large observational 
studies have been conducted in the US, where the majority showed a small or 
moderate increase in cancer detection although a more significant reduction of 
the recall rates, albeit the recall rates are substantially higher in the US 
compared to in Europe. The trials and observational studies will be discussed 
in terms of screening performance measures and what further evidence will be 
needed before DBT can be introduced in routine screening. None of the trials 
were designed or powered to assess long-term outcomes such as breast 
cancer mortality. An important surrogate measure will be interval cancer rates. 
Health economic analyses will add further knowledge. 
Learning Objectives: 
1. To understand the current evidence for the potential use of digital breast 
tomosynthesis in screening. 
2. To know the differences between the prospective trials with tomosynthesis. 
Modern methods for MRI screening  
G.M. Newstead; Chicago, IL/US  
Early studies involving interpretation of an abbreviated MRI protocol (AB-MR) 
have shown equivalent sensitivity for cancer detection when compared to a full 
standard MRI, with only minimal decrease in specificity. This growing evidence 
suggests a benefit for the expanded use of breast MRI for screening of a larger 
section of the female population. In addition to the AB-MR protocol devised by 
Kuhl et al, standard diagnostic protocols currently used in clinical practice can 
be shortened to accomplish an effective abbreviated protocol for screening. 
Additionally, new protocols, referred to as ‘ultra-fast imaging’, are currently 
under development aimed towards imaging and sampling early kinetics at a 
faster rate, 4-8 seconds per time-point for a bilateral scan. These new methods 
pose an exciting challenge. The challenge will be to develop streamlined, 
efficient, workflow to allow for rapid screening at a lower cost. The excitement 
will come from our ability to improve the detection of an increased number of 
small cancers, most of them node negative, for the benefit of a much larger 
population of women. Key to this process will be a faster MRI protocol, efficient 
throughput, and advanced training for radiologists in the interpretation of MRI 
screening studies. 
Learning Objectives: 
1. To review the technical challenges of breast MRI screening and learn how to 
overcome them. 
2. To discuss the future direction of breast MRI screening and the probable 
impact on clinical practice. 
14:00 - 15:30 Studio 2016  
jointly organised by Siemens Healthcare and Bayer HealthCare  
SY 1c  
Digital breast tomosynthesis out of the 
daily routine  
Moderator:  
S. Zackrisson; Malmö/SE  
The role of the synthetic mammogram?  
C. Van Ongeval, J. Soens, M. Keupers, S. Maeyaert, L. Cockmartin, H. 
Bosmans; Leuven/BE  
Comparison of combined 2D digital mammography and digital breast 
tomosynthesis with synthetically reconstructed mammograms and digital breast 
tomosynthesis in a diagnostic setting.  
Learning Objectives: 
1. To describe the advantages of the combined use of synthetically 
reconstructed mammograms and breast tomosynthesis in a diagnostic 
environment. 
2. To evaluate the image quality of the new synthetic mammogram Insight 
(Siemens) compared to 2D digital mammography. 
3. To compare the diagnostic accuracy of this synthetically reconstructed 
mammograms with breast tomosynthesis versus 2D mammograms with breast 
tomosynthesis. 
The challenge of reading breast tomosynthesis images  
K. Lang; Malmö/SE  
If breast tomosynthesis is to be used as a screening modality, the reading time 
will be one of the main challenges. It takes approximately 2-4 times longer to 
read a tomosynthesis image volume compared to conventional mammography 
(Good 2008, Gur 2009, Bernardi 2012, Astley 2013, Skaane 2013). The 
reading time is mainly affected by the type of imaging protocol used, i.e. one or 
two projections, as a stand-alone modality or combined with mammography. 
The average reading time has been reported to be 77 s for the so-called 
combination mode (mammography plus two-view tomosynthesis) compared to 
33 s for mammography (Bernardi 2012), and 30 s for one-view tomosynthesis 
(Dustler 2013). The reading time can be influenced by different image 
presentations, such as slabbing, cineloop speed and image orientation. 
Reading strategies for conventional mammography, such as mirror image 
interpretation (dx vs. sin), are not necessarily applicable in the reading of 
tomosynthesis image volumes, but other search strategies such as the so-
called drilling strategy (quickly scroll through the depth of the volume while 
keeping their eye position relatively constant) might be useful. However, further 
research is needed to find efficient search strategies and/or image 
presentations, where eyetracking studies on volumetric image perception could 
provide some answers. The utilisation of a CAD system might also be 
necessary to meet the increased workload on radiologists if tomosynthesis 
becomes the next screening modality. 
Learning Objectives: 
1. To understand the challenges of reading breast tomosynthesis Images. 
2. To learn how to read breast tomosynthesis images efficiently. 
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 Influence of digital breast tomosynthesis on BI-RADS classification  
J. Barkhausen; Lübeck/DE  
Mammography is the most important breast imaging technique allowing the 
visualization of masses and micro-calcifications. However, in conventional 
mammography the three-dimensional breast tissue is reduced to a two-
dimensional image. Therefore, small lesion may be undetectable due to 
superimposed glandular tissue. Digital breast tomosynthesis (DBT) emerged 
as a new imaging modality to overcome this limitation. Several studies have 
shown that tomosynthesis improves both tumour detection and the 
characterization of focal masses. Due to the cross-sectional nature of DBT the 
techniques allows on the one hand the reliable differentiation of true focal 
masses from summation artefacts. On the other hand, tomosynthesis improves 
the detailed analysis of the lesions’ border to differentiate benign lesions and 
carcinomas. The additional information provided by DBT has impact on the BI-
RADS classification of masses. In some case DBT leads to lower BI-RADS 
classes reducing recall rates or avoiding unnecessary biopsies whereas in 
other patients DBT detects new lesions resulting in higher BI-RADS classes, 
thus improving cancer detection rates. However, there is still a remaining 
uncertainty about the diagnostic accuracy of tomosynthesis in detecting 
microcalcifications. We need more clinical studies demonstrating that DBT is 
not inferior to full-field digital mammography in the detection and 
characterization of microcalcifications before we can answer the question of 
whether DBT can replace mammography. In summary, the most recent clinical 
studies confirm that in both selected and screened populations, the addition of 
tomosynthesis to digital mammography led to improved diagnostic accuracy 
and an increase in cancer detection rates. 
Learning Objectives: 
1. To understand the influence of DBT on BIRADS classification. 
2. To get familiar with the results of the most recent clinical trials. 
3. To learn about use of DBT in different clinical scenarios. 
Diagnostic performance of digital breast tomosynthesis in the detection 
and characterisation of microcalcifications  
M. Bernathova; Vienna/AT  
Detection and evaluation of microcalcifications are an important part of 
mammographic analysis. Microcalcifications are present in about half of the 
cases of non-palpable breast malignancies and simultaneously they are 
responsible for detection of almost 95 % of DCIS in screening. Introduction of 
tomosynthesis offers a new 3D aspect in detection and assessment of 
microcalcifications. Digital mammography and tomosynthesis are similar 
techniques in their origin, but different in their approach, thus it is fundamental 
to know the technical background of both and their consequent influence on 
the image quality in imaging of microcalcifications. Technical developments are 
very promising regarding new processing tools for more efficient detection and 
more accurate assessment of microcalcifications. 
Learning Objectives: 
1. To understand the usefulness of DBT in a screening setting. 
2. To understand the usefulness of DBT in a clinical setting. 
3. To know the different approaches of DBT. 
Evaluation of different approaches of tomosynthesis examinations  
L.J. Pina Insausti; Pamplona/ES  
Since its introduction, digital breast tomosynthesis (DBT) has become an 
important adjunct tool to digital mammography (DM). According to some 
studies, DBT could even substitute DM. DBT has been used in two different 
settings: screening setting: three prospective population-based trials have 
been evaluated (Mälmo, Oslo and STORM trials). The first one compared DBT 
alone in one view (MLO) vs. DM, and the detection rate increased by 43% with 
DBT. The other trials compared the combination DM + DBT (two views MLO 
and CC) vs. DM, showing an increase of the detection rate (31% and 33%). All 
the trials demonstrated an important increase in the detection of invasive 
cancers (59%, 40%, 49%). According to these results, breast cancer screening 
should be performed with DM + additional DBT or even with DBT alone. 
However, a 2D view is thought to be necessary for comparison with previous 
mammograms and for a quick overview of the case. Clinical setting: DBT has 
been found to be useful as a problem solving technique; DBT is at least as 
good as spot compression for the evaluation of breast lesions; DBT is useful to 
evaluate non-calcified breast lesions (better evaluation of the shape and 
margins of breast masses, better evaluation of architectural distortions and 
asymmetries); DBT can play a role in the evaluation of microcalcifications. 
Learning Objectives: 
1. To understand the usefulness of DBT in a screening setting. 
2. To understand the usefulness of DBT in a clinical setting. 
3. To know the different approaches of DBT. 
16:00 - 17:00 Studio 2016  
jointly organised by Siemens Healthcare and Bayer HealthCare  
SY 1d  
Multimodality discussion of clinical cases: 
breast imaging for therapy control  
Moderator:  
C. Van Ongeval; Leuven/BE  
Breast MRI perspective  
E. Wenkel; Erlangen/DE  
Costs, radiation dose and available time are generally in conflict with the need 
for frequent, dedicated and detailed information on treatment progression. 
Monitoring therapeutic success is typically performed where there is still a 
measurable tumour presence, such as during neo-adjuvant chemotherapy in 
primary cancer treatment. Another typical clinical setting is the early detection 
of loco-regional breast cancer recurrence. In both cases, ongoing but 
unsuccessful courses of treatment can be modified or new treatment strategies 
initiated on the basis of breast imaging results, and clinical examinations, 
mammography/tomosynthesis, ultrasound or MRI can be performed to show 
the tumour burden. The time frame and order of these examinations depend to 
some extent on specific guidelines but are also partially dictated by the 
preferences of referring physicians. Additionally, if a patient is part of a clinical 
study, then the frequency and choice of imaging modality can further be 
contingent on any particular study requirements. Selecting the correct imaging 
modality and follow-up scheme to monitor the effect of neo-adjuvant therapy on 
breast cancer and patients has a significant impact on diagnostic accuracy as 
well as on treatment delay times and costs. 
Learning Objectives: 
1. To discover the advantages of basic imaging methods such as ultrasound 
and breast tomosynthesis. 
2. To establish when only basic examinations are sufficient and from what 
point additional breast MRI is warranted. 
Mammography/tomosynthesis perspective  
M. Bernathova; Vienna/AT  
Please refer to the abstract of E. Wenkel; Erlangen/DE  
Ultrasound perspective  
M. Golatta; Heidelberg/DE  
Please refer to the abstract of E. Wenkel; Erlangen/DE  
12:30 - 13:30 Room O  
organised by MINT Medical  
SY 2 
Programme not available by date of publication  
12:30 - 13:30 Room N  
organised by SuperSonic Imagine  
SY 3 
Programme not available by date of publication  
12:30 - 13:30 Room L8  
organised by Mindray  
SY 4 
Programme not available by date of publication  
  
  




Thursday, March 3 
12:30 - 13:30 Room O  
organised by Siemens Healthcare  
SY 5 
Programme not available by date of publication  
12:30 - 13:30 Room N  
organised by Siemens Healthcare  
SY 6  
First clinical experiences with new Twin 
Robotic X-ray imaging  
Moderator:  
A. Hebecker; Erlangen/DE  
The Multitom Rax - the new versatility in diagnostic imaging: experiences 
from the first installed system  
W. Wüst; Erlangen/DE  
With the new Multitom Rax x-ray, fluoroscopy and angiography examinations 
can be performed with one diagnostic system. Flat panel detector technology 
allows visualisation of bone with high spatial resolution and the integrated 3D 
tool imaging of the head and neck region like DVT systems. We report the first 
clinical experiences with this prototype with the emphasis on the 
multifunctionality of this new system. 
Back to the future with 3D roentgenography: a travelogue of a journey 
into the third dimension and an outlook of what may lie ahead  
R.M. Benz; Basel/CH  
For the new Multitom Rax equipped with cone beam technology, a novel 3D 
imaging tool was developed and integrated into a conventional x-ray unit to 
permit acquisition of 3D data sets. We report our first scientific and clinical 
experiences with this prototype in a clinical setting with a focus on 
musculoskeletal applications. We aim to give an insight into image quality and 
clinical image aspect. Based on our initial experiences we will take a look 
ahead and discuss promising future applications. 
First experience with the Multitom Rax  
F. Jensen; Malmö/SE  
Abstract not available by date of publication  
12:30 - 13:30 Studio 2016  
organised by GE Healthcare  
SY 7 
Programme not available by date of publication  
12:30 - 13:30 Room E1  
organised by Bracco  
SY 8 
Programme not available by date of publication  
12:30 - 13:30 Room K  
organised by Toshiba  
SY 9 
Programme not available by date of publication  
12:30 - 13:30 Room G  
organised by Samsung 
SY 10 
Programme not available by date of publication  
12:30 - 13:30 Room M 2  
organised by Bayer Pharma  
SY 11  
Update and understanding on Gd deposits  
Moderator:  
V.M. Runge; Berne/CH  
Gd deposits in preclinical perspective  
H. Pietsch; Berlin/DE  
Abstract not available by date of publication  
What do we know from the clinical research?  
A. Radbruch; Heidelberg/DE  
Abstract not available by date of publication  
12:30 - 13:30 Room M 5  
organised by Bayer HealthCare  
SY 12  
Dose registries: strength in numbers for 
quality management, DRLs and research  
Moderator:  
M. Forsting; Essen/DE  
Concept and goals for the 1st patient-dose-register in Germany  
M. Forsting; Essen/DE  
Abstract not available by date of publication  
Setting the course for practical DRLs: a regional dose registry in 
Switzerland  
S.T. Schindera; Basle/CH  








Friday, March 4 
12:30 - 13:30 Room O  
organised by Philips  
SY 13  
Programme not available by date of publication  
12:30 - 13:30 Room N  
organised by Siemens Healthcare  
SY 14  
Extending the boundaries of ultrasound  
Moderator:  
C.F. Dietrich; Bad Mergentheim/DE  
The fortuitously discovered focal liver lesion  
C.F. Dietrich; Bad Mergentheim/DE  
The incidentally discovered liver lesion is a common problem. Consensus 
might be expected in terms of its work-up, and yet there is none. This stems in 
part from the fact that there is no preventive campaign for the early detection of 
liver tumours other than for patients with known liver cirrhosis and oncological 
patients. The work-up (detection and differential diagnosis) of liver tumours 
comprises theoretical considerations, history, physical examination, laboratory 
tests, standard ultrasound, Doppler ultrasound techniques, contrast enhanced 
ultrasound (CEUS), computed tomography (CT) and magnetic resonance 
imaging (MRI) as well as image-guided biopsy. Contrast enhanced ultrasound 
techniques have proved to be the most pertinent method. Contrast enhanced 
ultrasound techniques became part of the clinical routine about 10 years ago in 
Europe and Asia and are used for a variety of indications in daily clinical 
practice. CEUS is in many cases the first and also decisive technical 
intervention for detecting and characterising liver tumours. This development is 
reflected in many CEUS guidelines, e.g. in the EFSUMB guidelines 2004, 2008 
and 2012 as well as the WFUMB-EFSUMB guidelines recently published. This 
presentation sets out considerations to make a structured work-up of incidental 
liver tumours feasible.  
Normal, fibrosis or cirrhosis? NICE guidelines on VTq assessment and 
cost-effectiveness  
P.S. Sidhu; London/UK  
The use of non-invasive techniques to pre-assess patients with underlying 
diffuse liver disease is paramount in the work-up, with the potential to reduce 
the number of diagnostic liver biopsies, and to reduce healthcare costs. A 
number of serological markers are employed to predict the presence of fibrosis 
or cirrhosis, with both ultrasound and magnetic resonance imaging assuming 
an increasingly important role. Ultrasound machines now incorporate point 
shear wave technology, using acoustic radiation force impulse (ARFI) imaging 
(VTq™, Siemens) to document the stiffness of the liver by measuring the 
velocity of a ‘lateral shear wave’ and translate this to the degree of liver fibrosis 
(commonly using the Metavir Score). A quantitative measure allows for the 
avoidance of biopsy when normal values are obtained, and when values 
clearly indicate advanced disease. Studies demonstrate that VTq is a reliable 
non-invasive technique for liver fibrosis assessment, and the National Institute 
of Clinical Excellence (NICE) of the United Kingdom has issued guidelines to 
indicate the usefulness of the technique and compared the cost-effectiveness 
of deploying the method in the workup of diffuse liver disease. The review 
reported favourably for cost savings and accuracy. The ability to differentiate 
normal from advanced fibrosis and cirrhosis is clear, early fibrosis remains a 
challenge.  
The role of a new tissue strain analytics technology VTIQ together with 
contrast enhanced ultrasound in testicular lesions  
D.-A. Clevert; Munich/DE  
Ultrasound is a sensitive and accurate technique for the evaluation of testicular 
abnormalities, and is widely accepted as the first-line imaging technique and 
the gold standard for many common and uncommon testicular diseases but 
does not provide a histological diagnosis. Due to the continuous development 
of modern ultrasonography such as high frequency transducers, color Doppler 
and Real-time Elastography, ultrasonography and contrast enhanced 
ultrasound is considered the imaging modality of choice in small parts and 
scrotal disorders. Real-time Elastography has been introduced over 20 years 
ago for making non-invasive measurements of the mechanical properties of 
tissue and for imaging the elasticity of biological tissue. Virtual touch tissue 
imaging quantification (VTIQ) is a new imaging modality that together with 
contrast enhanced ultrasound estimates tissue stiffness and tissue perfusion in 
real time.  
12:30 - 13:30 Studio 2016  
organised by GE Healthcare  
SY 15  
Women's health imaging: advances in 
screening and diagnostic procedures  
Moderator:  
L. Katz; Buc/FR  
DBT vs mammography in a randomised population-based screening trial: 
initial results  
P. Pattacini; Reggio Emilia/IT  
Abstract not available by date of publication  
3D automated breast-ultrasound (ABUS) combined with digital 
mammography: a responsible approach for screening women with dense 
breasts  
L. Tabar; Falun/SE  
Abstract not available by date of publication  
MRI for women with a high risk of breast cancer  
L. Martincich; Candiolo/IT  
Abstract not available by date of publication  
12:30 - 13:30 Room E1  
organised by Bracco  
SY 16  
Programme not available by date of publication  
12:30 - 13:30 Room F2  
jointly organised by Siemens Healthcare and Bayer HealthCare  
SY 17  
Synergies in CT for better patient care  
Moderator:  
J.E. Wildberger; Maastricht/NL  
Individualised contrast enhanced CT scans in clinical practice - 
challenges and solutions  
J.E. Wildberger; Maastricht/NL  
Abstract not available by date of publication  
TwinBeam dual energy - clinical relevance in daily routine  
B. Jankharia; Mumbai/IN  
Abstract not available by date of publication  
Latest news on dual source CT - imaging without compromises  
T.G. Flohr; Forchheim/DE  
Abstract not available by date of publication  
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 12:30 - 13:30 Room K  
organised by Bracco  
SY 18  
Programme not available by date of publication  
12:30 - 13:30 Room G  
organised by Guerbet 
SY 19  
Brain gadolinium retention related to 
whole body multiple injections in MRI  
Moderator:  
A.J. van der Molen; Leiden/NL  
Experts:  
M.M. Thurnher; Vienna/AT  
T.H. Helbich; Vienna/AT  
T. Leiner; Utrecht/NL  
This session will be in the form of a debate.  
12:30 - 13:30 Room M 3  
organised by HIMSS (Healthcare Information and Management 
Systems Society)  
SY 20  
Programme not available by date of publication  
14:00 - 15:30 Room C  
organised by Hologic  
SY 21  
High volume screening with 3D 
mammography  
Moderators:  
B. Martins; Brussels/BE  
P. Skaane; Oslo/NO  
Programme not available by date of publication  
14:00 - 15:30 Room Z  
organised by Bayer HeathCare Russia  
SY 22  
Standards, guidelines and protocols 
improving diagnostic results in CT and 
MRI neuroimaging  
Moderators:  
I.N. Pronin; Moscow/RU  
I.E. Tyurin; Moscow/RU  
Introduction  
I.E. Tyurin; Moscow/RU  
Advances in contrast-enhanced MRI and CT of the brain and spine 
including advanced imaging techniques  
M. Essig; Winnipeg, MB/CA  
There have been recent advances in structural and functional neuroimaging 
that enable a better integration of the imaging results into the differential 
diagnostic, treatment decision and planning process as well as the follow-up 
assessment of CNS disease. Functional of physiologic imaging techniques 
have gained great interest in the management of different CNS diseases and in 
oncologic imaging. The use of contrast media is an important component of 
modern CNS imaging protocols and we have to understand the differences in 
contrast media performance and safety profiles. The presentation will give an 
overview on the use of contrast media in modern CNS protocols and 
challenges in respect of their safety and efficacy.  
Recommendations, protocols and modern technologies in 
neurooncology and neurotrauma (part I)  
I.N. Pronin; Moscow/RU  
N. Zakharova; Moscow/RU  
Modern neuroimaging technologies permit us to reveal brain tumours, their 
localization, extension, structure and, moreover, tumour blood supplying and 
malignancy degree. These possibilities help in differential diagnosis and 
postoperative imaging. Following the standard protocols does not exclude an 
individual approach to each patient. Neuroradiologists can modify standard 
protocols adding necessary advanced MRI-sequences or CT methods. Modern 
neuroimaging protocols for brain tumours and traumatic brain injury studies will 
be presented in this lecture. Routine (including contrast- enhanced imaging), 
advanced CT and MRI technologies will be also discussed. The essential use 
of contrast media for differential diagnostics will be emphasized. Neuroimaging 
protocols for intracerebral, extracerebral, metastatic tumours will be 
highlighted, and recommendations for their differential diagnosis will be given. 
Today CT is a method of choice for the acute traumatic brain injury. But in 
diffuse axonal injury it is necessary to use MRI in generally accepted and 
widespread sequences (T1, T2, T2-FLAIR, DWI), and advanced sequences 
such as gradient echo (SWI, SWAN) and diffusion tensor imaging (DTI).  
Non-oncologic neuroimaging: standards, protocols and 
recommendations  
V. Fokin; St. Petersburg/RU  
Various ways of MR neuroimaging in different clinics can cause inaccuracy in 
data interpretation and further disunity in the diagnostic and treatment process. 
Besides, dynamic observation requires a common approach. The aim is 
optimise diagnostic protocols in non-tumour diseases by means of their 
standardisation. The imaging protocol must be adapted to the equipment that 
is available (field strength, gradient performance, available sequences, etc.). 
The use of contrast media is an important component of modern 
neurovisualisation. In a patient with acute stroke, the imaging protocol should 
include non-contrast CT for differentiation of haemorrhage or ischemic stroke 
and/or DWI, that can reveal regions of acute cerebral infarction within minutes 
after symptoms onset. Perfusion-weighted imaging (PWI) can identify regions 
of brain with decreased perfusion and can be used to select candidates for 
endovascular therapy. The characteristic abnormalities of MS in the brain 
consist of multiple white-matter lesions with a high signal intensity on FLAIR, 
PD- and T2-WI and low signal intensity on T1-WI. It is important to assess 
presence of lesions in corpus callosum by means of sagittal T2-WI or FLAIR. 
Precontrast and postcontrast T1-WI must be made at least in axial plane, or T1 
MPRAGE can be performed. 5-20 minute delay is also necessary to provide 
sufficient time for GD to leak through the BBB. Alzheimer’s disease is one of 
the most common of all dementing disorders in the elders. It is a disease of 
gray matter, which demonstrates loss of cells from the cerebral cortex. T1 
MPRAGE is a sequence, that can provide very accurate gray matter volume or 
cortical thickness estimation using special postprocessing software. In patient 
with epilepsy, caused by hippocampal abnormalities it is important to visualise 
these structures in different planes with at least T1- and T2-WI, to find if any 
signal intensity or atrophy take place. Thus, standardisation of diagnostic 
protocols will help to improve the quality of diagnostic and treatment process in 
non-tumour diseases.  
Remarks and conclusions 
I.N. Pronin; Moscow/RU  
I.E. Tyurin; Moscow/RU  
14:00 - 15:30 Room O  
organised by GE Healthcare Russia  
SY 23  
Programme not available by date of publication  
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 14:00 - 15:30 Room G  
jointly organised by Bracco and Bayer HealthCare  
SY 24  
Programme not available by date of publication  
14:00 - 15:30 Room M 3  
organised by HIMSS (Healthcare Information and Management 
Systems Society)  
SY 25  
Programme not available by date of publication  
 
Saturday, March 5 
12:30 - 13:30 Room C  
organised by GE Healthcare  
SY 26  
Programme not available by date of publication  
12:30 - 13:30 Room O  
organised by Philips  
SY 27  
Programme not available by date of publication  
12:30 - 13:30 Room N  
organised by Philips  
SY 28  
Programme not available by date of publication  
12:30 - 13:30 Studio 2016  
organised by Bracco  
SY 29  
Programme not available by date of publication  
12:30 - 13:30 Room K  
organised by Toshiba  
SY 30  
Programme not available by date of publication  
 
